SMG
DGX icon

Spectrum Management Group’s Quest Diagnostics DGX Stock Holding History

Spectrum Management Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-70
Closed -$12K – 326
2021
Q4 		$12K Buy
+70
New +$10.7K ﹤0.01% 213
2020
Q1 		– Sell
-350
Closed -$37K – 260
2019
Q4 		$37K Sell
350
-150
-30% -$15.6K 0.02% 157
2019
Q3 		$54K Hold
500
– – 0.02% 138
2019
Q2 		$51K Sell
500
-200
-29% -$19.2K 0.01% 150
2019
Q1 		$63K Hold
700
– – 0.02% 126
2018
Q4 		$58K Buy
+700
New +$65.6K 0.02% 117

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Spectrum Management Group's DGX Position: Q1 2022 in Review

Spectrum Management Group sold out of Quest Diagnostics (DGX) in Q1 2022, closing a stake of 70 shares — an estimated $12K sold.

Spectrum Management Group first reported a position in DGX in Q4 2018 and held it in 6 quarters. The position peaked at $63K in Q1 2019. 851 funds tracked by Wall St. Rank hold DGX as of Q1 2022.

  • Spectrum Management Group reported no remaining Quest Diagnostics position as of Q1 2022 after selling out during the quarter.
  • Spectrum Management Group sold 70 Quest Diagnostics shares in Q1 2022, an estimated $12K.
  • Spectrum Management Group first reported a position in Quest Diagnostics in Q4 2018 and held it in 6 quarters.
  • Spectrum Management Group's Quest Diagnostics position peaked at $63K in Q1 2019.
  • 851 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2022.

Based on Spectrum Management Group's 13F filing for Q1 2022, filed 5 May 2022.